162 related articles for article (PubMed ID: 34940836)
1. N-terminal pro-brain natriuretic peptide and adverse outcomes in Chinese patients with hypertrophic cardiomyopathy.
Zhang ZL; Xu YY; Qin Z; Lu YZ; Liu TD; Zhang L; Shangguan JH; Wang W; Tang JN; Zhang JY
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34940836
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.
Wu G; Liu J; Wang S; Yu S; Zhang C; Wang D; Zhang M; Yang Y; Kang L; Zhao S; Hui R; Zou Y; Wang J; Song L
Heart; 2021 Oct; 107(19):1576-1583. PubMed ID: 33361398
[TBL] [Abstract][Full Text] [Related]
3. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
[TBL] [Abstract][Full Text] [Related]
4. The age, NT-proBNP, and Ejection Fraction Score as a Novel Predictor of Clinical Outcomes in CAD Patients After PCI.
Fan L; Zhang ZL; Tang JN; Guo QQ; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Yue XT; Bai Y; Dai XY; Zheng RJ; Zheng YY; Zhang JY
Clin Appl Thromb Hemost; 2022; 28():10760296221113345. PubMed ID: 35903893
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
[TBL] [Abstract][Full Text] [Related]
6. Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy.
Coats CJ; Gallagher MJ; Foley M; O'Mahony C; Critoph C; Gimeno J; Dawnay A; McKenna WJ; Elliott PM
Eur Heart J; 2013 Aug; 34(32):2529-37. PubMed ID: 23455360
[TBL] [Abstract][Full Text] [Related]
7. [Value of N-terminal pro-B-type natriuretic peptide on long-term outcome of patients with hypertrophic cardiomyopathy].
Meng XB; Wang WY; Zhang K; Qi Y; An SM; Wang SY; Zheng JL; Yu QJ; Tang B; Wu R; Wang SY; Gao CY; Tang YD
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):192-197. PubMed ID: 29562423
[No Abstract] [Full Text] [Related]
8. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
[TBL] [Abstract][Full Text] [Related]
9. Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy.
Sahin I; Gungor B; Ozkaynak B; Uzun F; Küçük SH; Avci II; Ozal E; Ayça B; Cetın S; Okuyan E; Dinckal MH
Clin Cardiol; 2017 Jan; 40(1):32-37. PubMed ID: 27768229
[TBL] [Abstract][Full Text] [Related]
10. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome.
Stiermaier T; Santoro F; Graf T; Guastafierro F; Tarantino N; De Gennaro L; Caldarola P; Di Biase M; Thiele H; Brunetti ND; Möller C; Eitel I
Clin Res Cardiol; 2018 Jul; 107(7):597-606. PubMed ID: 29675571
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study.
Liu HH; Cao YX; Jin JL; Guo YL; Zhu CG; Wu NQ; Gao Y; Zhang Y; Xu RX; Dong Q; Li JJ
Cardiovasc Diabetol; 2021 Apr; 20(1):84. PubMed ID: 33888145
[TBL] [Abstract][Full Text] [Related]
14. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
[TBL] [Abstract][Full Text] [Related]
15. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
[TBL] [Abstract][Full Text] [Related]
16. Preoperative NT-proBNP Predicts Midterm Outcome After Septal Myectomy.
Song C; Wang S; Guo Y; Zheng X; Lu J; Fang X; Wang S; Huang X
J Am Heart Assoc; 2019 Feb; 8(4):e011075. PubMed ID: 30760079
[TBL] [Abstract][Full Text] [Related]
17. Relationships between P wave dispersion, atrial electromechanical delay, left atrial remodeling, and NT-proBNP levels, in patients with hypertrophic cardiomyopathy.
Tuluce K; Ozerkan F; Yakar Tuluce S; Yavuzgil O; Gurgun C; Bilgin M; Kahya Eren N; Kocabas U; Nalbantgil S; Soydas Cinar C
Cardiol J; 2015; 22(1):94-100. PubMed ID: 24671901
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Future Atrial Fibrillation Development in Patients with Hypertrophic Cardiomyopathy: A Prospective Follow-Up Study.
Tuluce K; Yakar Tuluce S; Kahya Eren N; Kocabas U; Akyildiz Akcay F; Gunduz R; Akyildiz ZI; Ergene O
Echocardiography; 2016 Mar; 33(3):379-85. PubMed ID: 26493159
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of N-terminal prohormone brain natriuretic peptide for in-hospital and long-term outcomes in patients with infective endocarditis.
Wei XB; Liu YH; He PC; Yu DQ; Zhou YL; Tan N; Chen JY
Eur J Prev Cardiol; 2017 May; 24(7):676-684. PubMed ID: 28067531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
